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Motivation: : Gluten content from very foods, like barley, rye, wheat and in certain oat varieties, must be removed in 
individuals with celiac disease. Immune-based assays using monoclonal antibodies specific for these immunotoxic peptides 
would facilitate their detection in food. Two monoclonal antibodies, G12 and A1, were developed against a highly immunotoxic 
33-mer peptide.(1) 
In most of the Western countries, the level of gluten content in food to be considered as gluten-free products is below 20 parts 
per million measured by ELISA based on specific anti-gluten peptide antibody (2). The company Biomedal S.L. designed  
minimized single chain antibodies (scFv) in away they can produce by bacterias, which specifically recognize peptides of 
gluten (3).  The object of this work is to improve the production and specifity of these mini-antibodies. 
Methods: Several techniques have been used for the production of these scFv, like cloning and purifying in different strains. 
Enzyme-linked immunosorbent assays (ELISAs), affinity chromatography IMAC and Western blot analysis have been carried 
out to measure the sensitivity of these antibodies. 
Results: ELISA and Western blot methods showed that most of antibodies wasn’t functional because they get degraded. 
Conclusions: To improve the detection of gluten by these ScFv, the production will be carried out in other strain to prevent 
degradation of the antibody. 
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